Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations.
ACS Cent Sci
; 7(3): 467-475, 2021 Mar 24.
Article
in English
| MEDLINE | ID: covidwho-1132027
ABSTRACT
Starting from our previous finding of 14 known drugs as inhibitors of the main protease (Mpro) of SARS-CoV-2, the virus responsible for COVID-19, we have redesigned the weak hit perampanel to yield multiple noncovalent, nonpeptidic inhibitors with ca. 20 nM IC50 values in a kinetic assay. Free-energy perturbation (FEP) calculations for Mpro-ligand complexes provided valuable guidance on beneficial modifications that rapidly delivered the potent analogues. The design efforts were confirmed and augmented by determination of high-resolution X-ray crystal structures for five analogues bound to Mpro. Results of cell-based antiviral assays further demonstrated the potential of the compounds for treatment of COVID-19. In addition to the possible therapeutic significance, the work clearly demonstrates the power of computational chemistry for drug discovery, especially FEP-guided lead optimization.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Language:
English
Journal:
ACS Cent Sci
Year:
2021
Document Type:
Article
Affiliation country:
Acscentsci.1c00039
Similar
MEDLINE
...
LILACS
LIS